The event will be held in partnership with the International Society for Cell & Gene Therapy (ISCT) and the American Society of Gene and Cell Therapy (ASGCT). This partnership will take place through two important symposia with the participation of outstanding members of those and our society. We will also have on the second day of the event the 1st Symposium on the Use of Stem Cells and Biomaterials in Dentistry and on the third day the III Meeting on the Use of Stem Cells and Cell Therapy in Veterinary Medicine, these in parallel presentations.Among the activities of the event considered essential, it will be encouraged to send free themes that will be presented in the form of posters and those selected for the event will be published in the important Cytotherapy Journal. The six best of them will be chosen by a scientific committee very well selected and the ones that stand out most among these and among the posters received prizes in cash. I would like to point out that the deadline for submitting free themes will be short due to the magazine rules in which free themes will be published and that they should be sent in English. The International Society of Cell Therapy recognizing the difficult moment is offering the first five hundred registrants, from South America with the exception of Chile for legal reasons, the opportunity to join for free for two years, thus obtaining the important advantages, such as having access Cythoterpy, webinars, advantages in participating in congresses and other activities. In return we will be an additional affiliate company to the magazine. This offer demonstrates how important this partnership is to our society.
In this way, I encourage everyone to register as soon as possible and prepare the free topics that will be presented at the meeting. With the support of everyone involved in these areas in South America and Brazil, I ask you to be kind enough to help publicize the event, especially to undergraduate, graduate and post-doctoral students. I wish to see you soon.
Prof. Dr. Paulo Roberto Brofman
President of ABTCel and the
XI Brazilian Association of Cell and Gen Therapy
Professor Ana Liz G. Alves DVM MSc PhD Animal Biotechnology Graduate Program Coordinator Associate Professor of Equine Surgery Regenerative Medicine Science The São Paulo State University (UNESP - Univ Estadual Paulista) Faculty of Veterinary Medicine and Animal Science Dept. of Veterinary Surgery and Animal Reproduction Graduated in Veterinary Medicine at FMVZ - USP, São Paulo, SP (1989), Residency in Large Animals Surgery (1990) at FMVZ - Unesp, Master in Medical Pathophysiology (1994) at the same institution. PhD in Medical Pathology (1998) by the Faculty of Medicine of Unesp and Free Teaching in Surgery of Large Animals after a Public Competition held in 2008 by FMVZ - Unesp. He completed a 1-year Post-Doctorate at the Royal Veterinary College-University of London (2010/2011), under the supervision of Prof. Roger K W Smith, in the area of Equine Orthopedics and Regenerative Medicine. He is currently Associate Professor III through Progression in the Unesp Teaching Career Plan, obtained in 2014 by FMVZ-Unesp. She teaches classes to students of the 3rd, 4th and 5th years of graduation in Veterinary Medicine and Graduate Studies. She is a Permanent Professor and Coordinator of the Postgraduate Program in Animal Biotechnology at FMVZ - Unesp (Capes - note 5). She is a CNPq Research Fellow, level 2 since 2006. Her current research area is Regenerative Medicine, with a focus on Veterinary Orthopedics. She is the leader of the Regenerative Therapy Research Group. She published more than 150 articles in specialized journals and numerous presentations in the annals of events. She received 8 recent research awards and / or honors. She currently coordinates 5 research projects, with international collaborations. Conducts University Extension work since 1992 in the areas of Clinic and Surgery of Large Animals (since 1992) and Regenerative Medicine (since 2005), in the form of clinical surgical assistance, veterinary consultancy, theoretical-practical courses and assistance to schools in the state of São Paulo.
Ashley Umlauf is a Cell Culture and Cell Therapy Field Applications Scientist II (FAS) with ThermoFisher Scientific. Ashley leverages her significant experience in designing and developing numerous commercialized medical devices to act as a primary technical consultant for her cell and gene therapy customers. Ashley holds a B.S. degree in Biochemistry and Molecular Biology from the University of Wisconsin.
Biologist, Master and PhD in Physiology at the Ribeirão Preto School of Medicine at the University of São Paulo (FMRP / USP) and did a post-doctoral internship in Psychobiology at the Faculty of Philosophy, Sciences and Letters of Riberião Preto (FFCLRP) at USP. For more than six years, he has served as Technical Advisor to the Department of Science and Technology of the Department of Science, Technology, Innovation and Strategic Health Supplies of the Ministry of Health (DECIT / SCTIE / MS), where he currently holds the position of coordinator of the National Program Genomics and Precision Health, Genomas Brasil, instituted in August 2020. Biologist, Master and PhD in Physiology at the School of Medicine of Ribeirão Preto at the University of São Paulo (FMRP / USP) and did a post-doctoral internship in Psychobiology at the Faculty of Philosophy, Sciences and Letters of Riberião Preto (FFCLRP) at USP. Technical Advisor at the Department of Science and Technology of the Secretariat of Science, Technology, Innovation and Strategic Health Supplies of the Brazilian Ministry of Health (DECIT / SCTIE / MS), where he currently holds the position of Coordinator of the National Program Genomics and Precision Health, the Genomas Brasil, instituted in August 2020.
ASSISTANT PROFESSOR OF PATHOLOGY, MASSACHUSETTS GENERAL HOSPITAL AND HARVARD MEDICAL SCHOOL.
Graduated in medicine from the Federal University of Bahia (2009), master‘s degree in Biotechnology in Health and Investigative Medicine from Fiocruz (2012) and doctorate in Human Pathology from the Federal University of Bahia (2016). He has an MBA in health management from Fundação Getúlio Vargas (2017). He worked as a visiting researcher at the Neuroimmunology Laboratory at the San Raffaele Scientific Institute in Milan, Italy (2010-2011). He works as a Researcher in Public Health at the Gonçalo Moniz Institute (Fiocruz-BA) and as a Coordinating Physician at the Center for Biotechnology and Cell Therapy at the São Rafael Hospital (HSR), in Salvador, where he is also the Technical Responsible for the Cell Technology Center (CTC) ) of the HSR. Since 2018, he has worked as a collaborating scientist at the DOr Institute for Research and Education (IDOR). Participates in the current management of the Brazilian Association of Cell Therapy, as 1st secretary. CNPq level 2 productivity scholarship. He has experience in confocal microscopy, culture of mesenchymal stem cells, culture of neural cells, iPSC, development of preclinical studies in experimental models and clinical studies in the areas of cell therapy and regenerative medicine.
Bachelor on Pharmacy from Universidad Nacional de Colombia, and Doctor of Biological Sciences from Pontificia Universidad Javeriana. Associate Professor and Director of the Institute for the Study of Inborn Errors of Metabolism at Pontificia Universidad Javeriana. I have worked in gene therapy for Morquio A using AAV and lentiviral vectors, and currently I‘m exploring the use of CRISPR/Cas9 as gene therapy tool for several inborn errors of metabolism. I have also worked in the production and characterization of recombinant five lysosomal enzymes in microorganisms (bacteria and yeast) for the development of novel ERTs. I also worked in the application of bioinformatics tools for the study of the inborn errors of the metabolism, such as protein modeling, mutation effect, docking, and systems biology.
Graduated in Biological Sciences from the Federal University of Paraná (1990), master‘s degree in Genetics from the Federal University of Paraná (1996) and doctorate in Health Sciences from the Pontifical Catholic University of Paraná (2008). She is currently Assistant Professor at the Medical School of the Pontifical Catholic University of Paraná, Technical Responsible for the Center for Cellular Technology at the Pontifical Catholic University of Paraná and Biologist at the Hospital de Clínicas of the Federal University of Paraná. Has experience in Immunogenetics, Human and Medical Genetics and Tissue Culture. She mainly works on the following themes: histocompatibility, cell culture and stem cells.
Veterinarian, with post-graduation "latu sensu" in Veterinary Acupuncture by the Bioethicus institute and doctorate by the Faculty of Veterinary Medicine and Zootechnics at the University of São Paulo with an emphasis on stem cell therapy and acupuncture. Coordinator of the training course in Veterinary Ozone Therapy by Fisioanimal. Member of the Brazilian Association of Veterinary Acupuncture (ABRAVET), Brazilian Association of Ozone Therapy (ABOZ) and of the Brazilian Association of Veterinary Ozone Therapists (ABO3VET).
Dr. Charles Murry received his bachelor’s degree in chemistry from the University of North Dakota, followed by MD-PhD training at Duke University, where he studied myocardial ischemia-reperfusion injury. He did residency training in Pathology at the University of Washington, followed by fellowship training in vascular biology and diagnostic cardiovascular pathology. He is currently a professor in the departments of Laboratory Medicine & Pathology, Bioengineering, and Medicine/Cardiology at the University of Washington. Murry’s research focuses on stem cell biology, with an emphasis on understanding differentiation of the human cardiovascular system and using these cells to study diseases and to regenerate damaged tissues. His group is a world leader in heart regeneration and is working toward a clinical trial using cardiomyocyte therapy. In addition to running his research group, Dr. Murry is the director of the UW Institute for Stem Cell and Regenerative Medicine. He has served on many local, national and international committees, spoken widely about stem cells and cardiovascular medicine, and he has received numerous awards for teaching and scientific achievement. Dr. Murry is a member of the ISSCR Board of Directors and the ISSCR Clinical Translation Committee. Most recently, Murry moved part of his research group to Sana Biotechnology, where he now serves as Senior VP and Chief Scientific Officer for Cell Therapy. His team at Sana is working to bring stem cellbased heart regeneration into clinical trials.
Trained Ophthalmologist, over 20 years in strategic Medical Affairs and recognised experience in launching and network building in gene therapy. Leading ocular gene at Novartis with strategic global medical leadership in the ocular gene portfolio. Close collaboration with key cross-functional stakeholders on the Ocular Gene therapies pipeline to shape the access and outcomes for patients with inherited retinal diseases and other blinding diseases, leveraging recognized experience in launching and network building in Gene Therapy.
Graduated in Dentistry (1995), Master in Dentistry, Oral Pathology, by the Faculty of Dentistry, University of São Paulo (2002); PhD in Human Genetics by the Institute of Biosciences, University of São Paulo (2007). Post-doctorate in Human Genetics and Stem Cells at the Institute of Biosciences of the University of São Paulo (IB-USP) and at the University of California Los Angeles (UCLA), held from 2007 to 2011. General secretary of the Brazilian Association of Cleft Palates (management) 2005-2009). Postgraduate researcher and advisor (academic master‘s and doctorate) at the Teaching and Research Institute of Hospital Sírio-Libanês, where she develops basic and translational research in the area of stem cells, tissue bioengineering, cleft lip and craniofacial malformations. She is technically responsible for the Cell Processing Center of Hospital Sírio Libanês. Principal investigator of the Tissue Bioengineering Project for patients with craniofacial malformations using stem cells PROADI-SUS (Ministry of Health / Hospital Sírio Libanês) from 2012 to the present date (25000.009809 / 2018-2020). Member of the Clinical Body of the Municipal Hospital Infantil Menino Jesus since 2012, where she works as a Dental Surgeon, in the multidisciplinary team of care for patients with cleft lip and palate and conducts clinical research related to the treatment and rehabilitation of patients with congenital craniofacial malformations. She was a member of the multidisciplinary health council of the NGO "Operation Smile Brazil" from 2012 to 2020. In 2020 he coordinated the first online course on Bioengineering Tissues for the musculoskeletal system of Hospital Sírio-Libanês. Also in 2020, he coordinated the first International webnar at the Hospital Sírio Libanês / Ministry of Health (PROADI-SUS) "Innovations in the clinical treatment of tissue bioengineering in congenital malformations". She has experience in team leadership, assistance, teaching and research.
Chairman and Professor, Department of Dentistry and Oral and Maxillofacial Surgery, School of Medicine, Catholic University of Deagu, Republic of Korea. President and founding of World Academy of Ultrasonic Piezoelectric Bone Surgery (www.waups.org); Past President of ICOI Asia-pacific section and founding President of ICOI Korea (Korean Society of Oral Implantologists); Chair of 9th Congress of ICOI Asia Pacific Section and Co-congress chair of 28th ICOI World Congress and World Congress of Ultrasonic Piezoelectric Bone Surgery; Creator and disseminator of many techniques in regenerative medicine such as stick bone and dental graft.
MD, PhD, MSc; Head of Knee Surgery of Cajuru University Hospital (PUCPR); President of SBOT-Paraná (2021); Member of Regenerative Orthopedics and Cellular Therapy Commission of SBOT; Member of Scientific Commission of SBCJ; Reviewer of RBO.
Graduated in medicine at the Federal University of Rio de Janeiro (UFRJ, 2011), PhD in Sciences (Physiology) by the Biophysics Institute Carlos Chagas Filho (IBCCF), UFRJ (2013), Post-doctorates at the University of Vermont, USA, and IBCCF , UFRJ. Adjunct Professor at IBCCF, UFRJ, Young Scientist of Our State (FAPERJ), Researcher 2 at CNPq, Member of the Young Medical Leadership Program at the National Academy of Medicine, Member of the Network of Specialists in Advanced Therapies (RENETA).
Professor at the Federal University of Rio Grande do Sul (UFRGS), working on the development of innovative treatments for rare genetic diseases, especially focused on gene therapy and genome editing. He has more than 70 articles published in international journals, with a research productivity scholarship from CNPq level 2. Professor of the Graduate Programs in Physiology and in Genetics and Molecular Biology at UFRGS, having supervised 15 master‘s and doctoral thesis (in progress or completed).
Associate (Tenure) Professor Department of Histology and Embryology Faculty of Medicine Universidad de la República and Principal Investigator Neuroinflammation and Gene Therapy Laboratory Institut Pasteur Montevideo Uuruguay. Publications: https://pubmed.ncbi.nlm.nih.gov/?term=peluffo%2C+h&sort=date
Chair, Dept. Cariology, Restorative Sciences, Endodontics, University of Michigan School of Dentistry; Professor of Otolaryngology, University of Michigan School of Medicine; Professor of Biomedical Engineering, University of Michigan College of Engineering; Professor of Dentistry, University of Michigan School of Dentistry; President-Elect, American Association for Dental Research (AADR); Associate Editor, Journal of Dental Research; Member: 29 Editorial boards.
Biologist, Master in Cell Biology at UFPR and PhD in Medical Biochemistry at UFRJ. Additionally, she also has experience with developing innovation projects in Startups. At ThermoFisher, she is a technical specialist in Cell Biology, responsible for the portfolios for Cell Therapy, Gene Editing, Expression of Recombinant Proteins, Cell Culture among other topics.
Senior Specialist in Metrology and Quality at the National Institute of Metrology and Quality and Associate Professor at Universidade Federal Fluminense; PhD in Sciences by the Universidade Estadual de Campinas and post-doctorate in Cellular and Molecular Biology at the Institute of Chemistry at USP; Degree in biochemistry and cellular and molecular biology, works in the areas of biomaterials, bone biology and bioengineering with an emphasis on iocompatibility and toxicology of nanomaterials.
Graduation in Dentistry, Biologist, Specialist in Implantology, Master in Biochemistry (UNB), Doctor in Medical Sciences (UNB), Professor in the Medicine course at Universidade Federal de Brasília, Technical advisor to the Conselho Federal de Odontologia (CFO) for matters related to cells, blood, tissues and organs with ANVISA.
PhD at University of Edinburgh on the clonality of the haematopoietic stem cell system. EMBO Postdoctoral fellowship in Toronto, Samuel Lunenfeld research institute with Alan Bernstein. – Here I got interested in generating blood from embryonic stem cells (4 years from 1989-1993). MRC Senior Fellowship to set up my own lab in Edinburgh where I have been ever since.
Holds major degrees in Teaching (2009) and Bachelor (2010) in Biological Sciences at the University of São Paulo, at the Faculty of Philosophy, Sciences and Letters of Ribeirão Preto. He holds a master‘s degree (2012) and a doctorate (2016) in Sciences from the Ribeirão Preto Medical School (USP). He completed a post-doctorate (2019) at the Institut National de la Santé et de la Recherche Médicale (INSERM U935, France) in the field of therapeutic and neoplastic stem cells. Currently, he coordinates the Gene Transfer Laboratory at the Ribeirão Preto Blood Center (FMRP / USP), where he develops basic and applied studies in gene/cell therapy, with a special focus on genetically engineered T cells.
Manuela E. Gomes is Associate Professor and President of the I3Bs Research Institute of the University of Minho, Portugal. Her research interests currently focus on tendon tissue engineering strategies, namely in the development of scaffold materials and bioinks based on biodegradable natural origin polymers, stem cells sourcing and differentiation (using biochemical and physical methods). She graduated in Metallurgical and Materials Engineering, University of Porto, Portugal in 1997, obtained a MSc in Polymer Engineering, Univ. of Minho in cooperation with the company Isotis, Bilthoven (Holland), and a PhD in Materials Science and Engineering – Tissue Engineering/Hybrid Materials in collaboration with the Rice University (USA), in 2005. She was a co-founder of the 3B’s Research Group and one of the vice-directors of the group since 2011. Manuela Gomes is a board member of the Doctoral Program on Tissue Engineering, Regenerative Medicine and Stem Cells and is responsible for lecturing on biomaterials, tissue engineering and stem cells to Biomedical Engineering students of the University of Minho. She has been participated in numerous European and national/regional projects as PI or team member. She was awarded a Consolidator Grant from the European Research Council (ERC CoG) to develop magnetically assisted tissue engineering technologies for tendon regeneration and with a EC funded Twinning Project – “Achilles: Overcoming specific weaknesses in tendon biology to design advanced regenerative therapies”, in collaboration with NUI Galway (Ireland), University Regensburg Medical Centre (Germany) and the Mayo Clinic (USA). Manuela Gomes is editor 2 books and co-editor of the Tissue Engineering Encyclopaedia (Elsevier, 2019) and author of 44 book chapters, 200 full papers published in international refereed journals, and more than 300 communications in international conferences (7.900 citations, H-index of 47). She has received several awards, including the 2013 Young Investigator Award of the Tissue Engineering and Regenerative Medicine International Society – European Chapter (TERMIS-EU). Manuela Gomes is an active member of several international scientific organizations, being currently a member-at -large and chair of the membership committee of TERMIS, and Portugal Ambassador for the EORS.
PhD in Oral Pathology from FOUSP; Pos doc in Cell Biology at the NIH, United States. Full Professor at the FOUSP, at the Ibirapuera University and at the Aachen University, Germany. President elected of ABLOS and member of the ISLD executive board. Her research activity is focused on the effect of photobiomodulation therapy and antibacterial photodynamic therapy.
Ms. Oliveira holds a Biology degree from the State University of Campinas (Unicamp) and a Master of Science from the Department of Morphology and Genetics at the Federal University of São Paulo (Unifesp). A passionate scientist has over 10 years of experience in the life science industry and over 6 years of direct business support in the Cell and Gene Therapy market. Currently holds a product specialist title at Cytiva and is the technical responsible for Cell and Gene Therapy in Latin America.
Maroun Khoury is currently the Chief Scientific Officer of Cells for Cells and the co-founder of REGENERO: the Chilean Consortium for Regenerative Medicine. He also holds an associate Professor position at the Universidad of the Andes in Santiago, Chile. Maroun Khoury in the immediate past VP for the South and Central America for the International Society for Cellular Therapy (ISCT). He is the co-author of multiple preclinical studies in stem cells and clinical publications including a Phase I/II in heart failure and Osteoarthritis.
Graduated in Biological Sciences Medical Modality from the Federal University of Rio de Janeiro (2000) and doctorate in Biological Chemistry from the Federal University of Rio de Janeiro (2004). He is currently a researcher at the National Cancer Institute and a specialist at the Fundação Oswaldo Cruz Foundation, where he participates in the coordination of the FioC Cancer Network. He is a fellow of the Scientist of Our State (CNE) of FAPERJ, a member of the technical working chamber of ANVISA for advanced therapies and of the Global Outreach committee of the American Society of Gene & Cell Therapy. www.martinlab.net.
PROFESSOR OF PEDIATRICS (STEM CELL TRANSPLANTATION) STANFORD UNIVERSITY, SCHOOL OF MEDICINE
Assistant Professor of Dental Medicine in orthodontics and, director of the TMJ Biology and Regenerative Medicine Laboratory at Columbia University. Dr. Embree is an orthodontist and cell biologist with over 15 years of experience in the field of osteoarthritis and TMJ. She is a coinventor of StemGEL and a co-Founder and Scientific Advisory Board Chair of Wnt Scientific.
Coordinator Department Bone Marrow Transplant, Associação Portuguesa de Beneficência, SJ Rio Preto, SP. Brazil Past VP South and Central America International Society for Cellular Therapy (ISCT). Former Professor Hematology FM USP, SP. Brazil Former Editor Revista Brasileira de Hematologia e Hemoterapia.
Graduation in Dentistry, Specialist and Master in Oral and Maxillofacial Surgery at Universidade Federal do Rio de Janeiro; PhD in Oral Pathology at Universidade Federal Fluminense; Professor at PPGOdontologia UFF; Member of the Bioengineering Network of the State of Rio de Janeiro; Member of the NanoSaude Network, Faperj Scholarship Holder.
Chairman of Research Center for Regenerative Medicine and Tissue Engineering Concepcion, Chile; Facultad de Odontología, Universidad de los Andes, Santiago, Chile; Visiting Professor at Department of Oral Health Sciences / Periodontology; University Hospitals, Catholic University Leuven, Belgium; Developer of Natural Guided Regeneration-Therapy for tissue regeneration and wound healing.
Patricia Rocco, MD, PhD, Vice-President of ISCT for the South and Central America regions, Full Professor at the Federal University of Rio de Janeiro, where she heads the Laboratory of Pulmonary Investigation. Elected Member of the National Academy of Medicine in Brazil and Brazilian Academy of Science. Prof. Rocco has authored and co-authored more than 360 peer-reviewed publications and 120 book chapters.
Qualifications Date Awarding body Title of qualification 1979 Oxford University Batchelor of Arts II.1 (Biochemistry) 1983 University of London PhD Current position From (Date) Location Position October, 2007 University of Edinburgh Reader, School of Clinical Sciences Previous Posts held From (Date) Location Position 1984 Consultant Intelligenetics Corp. Palo Alto, California 1984-87 Dept of Medical Microbiology, Stanford University Medical School Research Fellow 1987-98 Dept of Crystallography, Birkbeck College, University of London Royal Society University Research Fellow 1998-2007 Anthony Nolan Research Institute Deputy Director of Research and Reader in Haematology, UCL
Graduated in Medicine (1975) and PhD in Biological Sciences (Biophysics, 1979), both from UFRJ, he did postdoctoral studies at Oxford University (1980-1982). He is currently Full Professor at UFRJ (since 1994) and Head of the Neurogenesis Laboratory (since 1985). A pioneer in Brazil in basic research in neurodegeneration and neuroprotection, he created and coordinated the project of the Millennium Institute of Gene Therapy (2005-2008), and is a member of the National Network of Specialists in Advanced Therapies (Reneta) of ANVISA. He is CNPq Researcher 1A, Scientist of Our State at FAPERJ, full member of the Brazilian Academy of Sciences, the Academy of Medicine of Rio de Janeiro, the Academy of Sciences of Latin America and TWAS. He received from the Brazilian Society of Neurosciences and Behavior (SBNeC) the Cesar Timo-Iaria Award for his contributions to Neurosciences and was awarded by the Presidency of the Republic with the Commendation (2001) and the Grand Cross (2007) of the National Order of Merit Scientific.
Graduated in Medicine at the Federal University of Rio Grande do Sul (1970), Master (1980) and Doctorate (1987) in Medicine: Cardiology, at the Federal University of RS. Full Professor at the Department of Surgical Clinic at UFCSPA (Federal University of Health Sciences of Porto Alegre). Coordinator of the Center for Congenital Heart Diseases at Hospital Moinhos de Vento, as Head of Pediatric Cardiology and Cardiac Surgery. He is a Cardiovascular Surgeon, Researcher and Professor Emeritus of the Postgraduate Program in Cardiology, of the Cardiology Institute of RS - University Foundation of Cardiology (IC-FUC), Institution where he was Coordinator of the Postgraduate Program (Master and Doctorate) of 1999 to 2002, Scientific Director from 2002 to 2011 and Coordinator of the Professional Master‘s Postgraduate Program in Health Research and Innovation Processes from 2013 to 2017; At IC-FUC, he created, among other initiatives, the Laboratory of Molecular and Cellular Cardiology, the Clinical Research Center (CEPEC-FUC) and the Telemedicine Center. Presides over the Cooperative of Cardiovascular Surgeons of Rio Grande do Sul since August 2012; Communication Director (Management 2008-2009) and Research Director (2010-2011) of the Brazilian Society of Cardiology - SBC; Scientific Director of the Brazilian Society of Cardiovascular Surgery (2016-2020); PQ2 researcher at the National Council for Scientific and Technological Development (CNPq). Member of the Advisory Committee of the Medical Area (CA-MD) CNPq (2005-2010). He coordinated the Rio Grande do Sul Cellular Therapy Network (2010-2014), with support from FAPERGS / CNPq / PRONEX. He is a member of the following Scientific Societies: Gaucho Society of Cardiovascular Surgery, Brazilian Society of Cardiovascular Surgery, The Society of Thoracic Surgeons (USA), Society of Cardiology of RGS, Brazilian Society of Cardiology - SBC, American Heart Association, American College of Cardiology and American Association for the Advancement os Science. Member of the Editorial Board of the Brazilian Journal of Cardiovascular Surgery / Brazilian Journal of Cardiovascular Surgery and the Brazilian Archives of Cardiology - SBC. Has experience in Cardiology, working on Cardiovascular Surgery for Adults and Pediatric Cardiac Surgery. Main lines of research: Atrial Fibrillation, Cardiovascular Surgery and Molecular Biology Applied to Cardiology.
Graduation in Dentistry at Universidade Federal do Rio de Janeiro; Specialization in Orthodontics, Association of Dental Surgeons of Campinas; Master‘s Degree in Medicine with a concentration in Head and Neck Surgery at Hospital Heliópolis and PhD in Medical Clinic (Neurology) at Universidade Federal do Rio de Janeiro; Professor at Faculdade de Medicina de Petrópolis and Coordinator of the Specialization Course in TMD and Orofacial Pain; Researcher with special interest in the areas of TMD and Orofacial Pain, Headaches, Genetics and Regenerative Medicine, the latter with an emphasis on the use of Cellular Therapies for Cartilage and Bone Regeneration; Principal Investigator in the first human clinical trial for TMJ regeneration using autologous nasal septum chondrocyte transplantation.
Dr. Roberto Giugliani, MD, PhD, is a medical geneticist with specialization in inherited metabolic diseases. He is Full Professor at the Department of Genetics of the Federal University of Rio Grande do Sul, being the founder and active member of the Medical Genetics Service of the University Hospital, in Porto Alegre, Brazil. He is also Editor-in-Chief of the Journal of Inborn Errors of Metabolism and Screening, Chairman of the Latin American School of Human and Medical Genetics (ELAG), and Member of Brazilian Academy of Sciences. He is past President of the Latin American Society of Inborn Errors of Metabolism and Newborn Screening (SLEIMPN), the Latin American Network of Human Genetics (RELAGH), and the Brazilian Society of Medical Genetics and Genomics (SBGM). Prof. Giugliani’s main interests are concentrated in screening, diagnosis, and treatment of inborn errors of metabolism, particularly of lysosomal storage diseases, having supervised the training of over 100 MSc and PhDs, and being author of more than 480 scientific papers.
Medical degree from Federal University of Rio de Janeiro (1977), Master (1980) and PhD (1985) in Biological Sciences from Federal University of Rio de Janeiro. Postdoctoral fellow at Yale University (1985-1987). Faculty member at Federal University of Rio de Janeiro since 1980. Vice-Director of the Carlos Chagas Filho Institute of Biophysics / UFRJ. Founding member and President of the Brazilian Association of Cellular and Gene Therapy (ABTCel). Titular member of the Brazilian Academy of Sciences (ABC) since 2006. National Order of Scientific Merit (2006). Currently Full professor at Federal University of Rio de Janeiro and Head of the Laboratory of Cellular and Molecular Neurobiology. Experience in the area of Neuroscience and Neurology working in basic, pre-clinical and clinical research with cell and gene therapies.
He has a degree in Chemistry, a Master‘s and a PhD in Biochemistry from the University of São Paulo, a post-doctorate in Gene Therapy from the University of Washington and a PhD in Biophysics from the Federal University of São Paulo. He was a professor of biochemistry at Unesp-Rio Claro between 1988-1996, and since 1996 he has been a professor of biophysics at Escola Paulista de Medicina da Unifesp. He is currently a full and active professor in the biophysics department at Unifesp. He was co-founder of the Interdisciplinary Center for Gene Therapy (CINTERGEN) at Unifesp, and was director since its foundation in 2004 until 2010 (the current name of CINTERGEN is CTCMol). He is a member of the Technical Chamber of Advanced Therapies at ANVISA and representative of specialists at RENETA-ANVISA. Since 2019, he has been vice president of the Brazilian Association of Cell and Gene Therapy. The main lines of research are: gene therapy for ischemic and genetic diseases, cancer and DNA vaccine.
Master in Biological Sciences - University of Buenos Aires (2007) and PhD in Biological Chemistry - University of Buenos Aires (2012). She completed a Post-Doctorate at Fundación Instituto Leloir- IIBBA- CONICET in the area of regenerative medicine. She is currently Research Assistant at Fundación Instituto Leloir- IIBBA CONICET, which work subject focus on cell-replacement therapy for Parkinson disease. She teaches classes at School of Sciences -University of Buenos Aires.
Graduation in Dentistry from Brazil and dentist qualified in the UK, who wants to push dentistry forwards through biology. He completed his MSc in Regenerative Dentistry and a PhD in Translational and Regenerative Dentistry at King‘s College London under Prof Paul Sharpe supervision, where he created a dentine self-healing technique fully based on genetic modulation and stem cell activation in the dental pulp. Currently, he holds an NIHR Clinical Lectureship position at KCL and is a Specialty Registrar in Periodontology at Guy‘s Hospital, in London, UK, where he is attempting to enhance periodontal disease prevention.